Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00567320 · ClinicalTrials.gov registry record · NA
Efficacy of Varenicline in Methadone-Stabilized Cocaine Users
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT00567320 is a NA study that has completed, run by Yale University. The registered enrollment target is 31 participants.
The verdict
NCT00567320, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
Cocaine addiction continues to be an important public health problem in the US with a significant cost to the individual and society. Among substance abusers, cocaine use has been recognized as a significant problem especially in methadone-maintenance patients. In several studies, rates of cocaine use have been reported to range from 30 to over 60 percent of those in methadone maintenance programs (Condelli et al. 1991; Hunt et al. 1984; Kidorf and Stitzer 1993; Kosten et al. 1988). In these patients, cocaine use seems to be a predictor of poor clinical outcome (Hartel et al. 1995; Kosten et al. 1987a). The development of effective pharmacotherapies for cocaine use disorders, especially in the opioid-dependent population is of great importance. Unfortunately, such effective pharmacotherapies do not exist. 1. To determine the safety and tolerability of varenicline in cocaine-using methadone-stabilized subjects. 2. To determine if varenicline is efficacious in reducing cocaine-use in methadone-stabilized subjects.
Interventions
- DRUG Varenicline
- DRUG Sugar pill or Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2007-03 |
| Est. Completion | 2009-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00567320
The ClinicalTrials.gov registry entry for NCT00567320 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Varenicline is the first listed.
NCT00567320 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00567320 about?
NCT00567320 is a clinical study titled "Efficacy of Varenicline in Methadone-Stabilized Cocaine Users". Cocaine addiction continues to be an important public health problem in the US with a significant cost to the individual and society. Among substance abusers, cocaine use has been recognized as a significant problem especially in methadone-maintenance patients. In several studies, rates of cocaine u...
What is the current status of trial NCT00567320?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2007-03. Estimated completion is 2009-08.
What interventions are being tested in trial NCT00567320?
The interventions under investigation include: Varenicline (DRUG), Sugar pill or Placebo (DRUG).
Who is sponsoring clinical trial NCT00567320?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.